NPPB and diabetes mellitus: A small study found that six months of dapagliflozin therapy significantly improved LV diastolic function (measured by E/e′ and left atrial volume index) in HFpEF patients with diabetes, despite no significant change in brain natriuretic peptide (BNP) levels [26].